Asosiy kontentga oʻtish
AkademScholar

Kashfiyot

Xizmatlar

Identifikatsiya

Ishlab chiquvchilar uchun

Ekotizim

Muassasalar

Shahid Beheshti University of Medical Sciences

Nom variantlari: SBMU

Davlat:
IR
ROR:
https://ror.org/034m2b326
7
h-indeks
544
Iqtiboslar
204
Asarlar
253
Mualliflar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
01325385005010015020020172018201920202021202220232024202520262017: Nashrlar 4, Iqtiboslar 12018: Nashrlar 8, Iqtiboslar 52019: Nashrlar 8, Iqtiboslar 52020: Nashrlar 25, Iqtiboslar 62021: Nashrlar 19, Iqtiboslar 102022: Nashrlar 30, Iqtiboslar 372023: Nashrlar 23, Iqtiboslar 872024: Nashrlar 25, Iqtiboslar 1202025: Nashrlar 26, Iqtiboslar 1822026: Nashrlar 18, Iqtiboslar 84

Iqtibos tarixi

05010015020020172018201920202021202220232024202520262017: Iqtiboslar 12018: Iqtiboslar 52019: Iqtiboslar 52020: Iqtiboslar 62021: Iqtiboslar 102022: Iqtiboslar 372023: Iqtiboslar 872024: Iqtiboslar 1202025: Iqtiboslar 1822026: Iqtiboslar 84

Nashr tarixi

01325385020172018201920202021202220232024202520262017: Nashrlar 42018: Nashrlar 82019: Nashrlar 82020: Nashrlar 252021: Nashrlar 192022: Nashrlar 302023: Nashrlar 232024: Nashrlar 252025: Nashrlar 262026: Nashrlar 18

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

03581020172018201920202021202220232024202520262017: h-indeks 12018: h-indeks 22019: h-indeks 22020: h-indeks 22021: h-indeks 32022: h-indeks 32023: h-indeks 42024: h-indeks 52025: h-indeks 72026: h-indeks 7

Eng koʻp iqtibos qilingan asarlar

  1. CAR-T cell combination therapy: the next revolution in cancer treatment20225 iqtibos
  2. AI-driven multi-omics integration in precision oncology: bridging the data deluge to clinical decisions20255 iqtibos
  3. Aptamer-based approaches in leukemia: a paradigm shift in targeted therapy20255 iqtibos
  4. Platelet-derived extracellular vesicles: emerging players in hemostasis and thrombosis20254 iqtibos
  5. Side effects of using disinfectants to fight COVID-1920202 iqtibos
  6. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 201720192 iqtibos
  7. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 201920211 iqtibos
  8. “Mesenchymal stem cell-derived exosomes (MSC-exosomes) in hematology: From mechanisms to clinical breakthroughs”20251 iqtibos
  9. Epigenetic mechanisms and next-gen editing platforms in hematology: From molecular basis to therapeutic frontiers20251 iqtibos
  10. An odyssey of monoclonal gammopathies: focusing on precursors and the progression from MGUS and SMM to multiple Myeloma, with a brief overview of novel therapeutic strategies20261 iqtibos